ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,629.00
0.55%
S&P ASX All Technology
3,016.30
1.48%
Brent Oil
82.765
0.00%
US Dollar vs AUD
1.514
-0.05%
Bitcoin
63,665.15
1.23%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amarin Corp PLC (AMRN)

  7. Amarin Corp PLC (AMRN) News

AMRN

Amarin (AMRN)

Amarin Corp PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AMRN
DateTimeSourceHeadlineSymbolCompany
01/05/202421:00GlobeNewswire Inc. Amarin Reports First Quarter 2024 Business Update and Financial ResultsNASDAQ:AMRNAmarin Corp PLC
25/04/202404:00GlobeNewswire Inc.Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular EventNASDAQ:AMRNAmarin Corp PLC
22/04/202422:00GlobeNewswire Inc.Amarin Announces Results of Annual General Meeting of ShareholdersNASDAQ:AMRNAmarin Corp PLC
15/04/202422:00GlobeNewswire Inc.Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024NASDAQ:AMRNAmarin Corp PLC
08/04/202422:00GlobeNewswire Inc.Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24NASDAQ:AMRNAmarin Corp PLC
08/04/202420:30PR Newswire (Canada)New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient SubgroupsNASDAQ:AMRNAmarin Corp PLC
07/04/202405:30GlobeNewswire Inc.New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient SubgroupsNASDAQ:AMRNAmarin Corp PLC
03/04/202423:00GlobeNewswire Inc.Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in EuropeNASDAQ:AMRNAmarin Corp PLC
25/03/202423:00GlobeNewswire Inc.Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & ExpoNASDAQ:AMRNAmarin Corp PLC
05/03/202409:30Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:AMRNAmarin Corp PLC
05/03/202400:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AMRNAmarin Corp PLC
29/02/202423:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:AMRNAmarin Corp PLC
29/02/202423:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corp PLC
29/02/202423:00GlobeNewswire Inc.Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:AMRNAmarin Corp PLC
16/02/202400:00GlobeNewswire Inc.Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024NASDAQ:AMRNAmarin Corp PLC
13/02/202400:00Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:AMRNAmarin Corp PLC
10/02/202408:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
10/02/202408:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
10/02/202408:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
03/02/202408:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
03/02/202408:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
03/02/202408:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
26/01/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corp PLC
25/01/202408:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
22/01/202423:30GlobeNewswire Inc.Amarin Chairman & CEO Issue Letter to ShareholdersNASDAQ:AMRNAmarin Corp PLC
13/01/202409:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
13/01/202409:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
13/01/202409:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AMRNAmarin Corp PLC
10/01/202423:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AMRNAmarin Corp PLC
10/01/202423:00GlobeNewswire Inc.Amarin Provides Preliminary Fourth Quarter 2023 Selected Financials and Outlines Key Priorities For 2024NASDAQ:AMRNAmarin Corp PLC
 Showing the most relevant articles for your search:NASDAQ:AMRN

Your Recent History

NYSE
DIS
Walt Disney
FX
AUDCAD
AUD vs CAD
FX
EURAUD
Euro vs AUD
NYSE
MCD
McDonalds
ASX
WPL
Woodside Petroleum
NASDAQ
GOOGL
Alphabet
NASDAQ
TSLA
Tesla
COIN
BTCUSD
Bitcoin
NASDAQ
AAPL
Apple
FX
AUDUSD
AUD vs US Dollar
SPI
SP500
S&P 500
ASX
FMG
Fortescue
ASX
XFL
S&P ASX 50
ASX
CSL
CSL
ASX
XMM
S&P ASX 300 Metals and M...
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved